Delivery Order SPE2DR25D1205-SPE2DR26F0WB9
- Not listed
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for supply of Zeposia 0.92 mg capsules (30-count units) with a completion date of June 17, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, the vendor's corporate headquarters. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $4,620.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units). This non-set-aside delivery order, with an ultimate completion date of October 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.94 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count package) under a firm fixed price arrangement. This non-competitive, non-set-aside delivery order was awarded on October 28, 2025, with an ultimate completion date of November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,862.82 for Zeposia 0.92 mg capsules (30-count units) with a firm fixed price arrangement. The contract, which was not subject to a set-aside designation, was awarded on October 31, 2025, with an ultimate completion date of November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zeposia 0.92 mg capsules (30-count units) with a contract value of $4,620.93. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by September 25, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a $13,862.79 delivery order to AmerisourceBergen Drug Corp for Zeposia 0.92 mg capsules (30-count units) on September 10, 2025, with an ultimate completion date of October 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,483.72 for Zeposia 0.92 mg capsules (30-count) on September 24, 2025, with completion scheduled for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $13,862.79 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count) under a firm fixed price contract. The award, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, represents a non-competitive, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract valued at $13,862.79. This non-set-aside competitive award, with an ultimate completion date of August 18, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,620.93 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zeposia 0.92 mg capsules (30-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 7, 2025. The contractor will perform fulfillment from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0WB9Delivery Order
The Defense Logistics Agency awarded a $14,609.25 delivery order to AmerisourceBergen Drug Corp for supply of Zeposia 0.92 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 3, 2025, with completion expected by November 25, 2025, represents a non-competitive set-aside delivery order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is a child contract under the larger SPE2DX IDC, a $999.999 billion prime vendor agreement running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Zeposia, a specialty pharmaceutical used in treating autoimmune conditions, exemplifies the company's role in supporting military medical supply chains through competitively-awarded, firm fixed-price transactions that range from minimal to substantial order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 11/3/25 |